NORCROSS, Ga., Aug. 17 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that it has signed a supply agreement with the American Red Cross for 19 Galileo systems for its five U.S. National Testing Laboratories."The American Red Cross is one of the largest and most prestigious health care organizations in the United States and these five laboratories test approximately seven million units of blood annually," said Dr. Gioacchino De Chirico, President and CEO of Immucor. "We are very pleased the American Red Cross has chosen the Galileo system for its laboratories. We expect these instruments to generate a total of at least $5 million a year in new reagent revenue after they are all live, depending on the amount and type of testing done on each instrument."
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra